Lin et al. have used a high-throughput chemical screening of patient-derived DIPG cultures along with RNAseq analysis to identify HDAC inhibitor panobinostat, as a potential therapeutic agent for DIPG [33]. Here, HDAC9 is linked to diffuse intrinsic pontine glioma.